A method of reducing damage to cells and tissue caused by an ischemic or hypoxic event is disclosed. The method includes administering to the cell or tissue, either in vivo or ex vivo, .psi..epsilon.RACK peptide. The peptide can be administered before, during or after the ischemic or hypoxic event.

 
Web www.patentalert.com

< Tissue engineered blood vessels and apparatus for their manufacture

< Artificial valve

> Ortho-substituted anthranilic acid amides and their use as medicaments

> Wortmannin analogs and methods of using same
~ 00277